1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Orchid Ventures, Inc.

Orchid Ventures, Inc.

ORVRF
Orchid Ventures, Inc.US flagOther OTC
0.00
USD
- -
- -
524.00Market Cap
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2021 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
2.79
0.13
0.03
Basic EPS, GAAP
- -
-0.36
-0.08
-0.1
-0.05
-0.04
-0.38
-0.14
-3.39
-0.11
-0.07
Free Cash Flow per Basic Share
- -
-0.31
-0.19
-0.09
-0.02
- -
-0.01
-0.35
-3.07
-0.06
-0.06
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
0.27
0.22
0.09
0.04
-0.29
-0.4
0.1
-0.11
-0.19
-0.15
Tangible Book Value per Share
- -
0.39
0.25
0.11
0.06
0.01
-0.34
0.13
1.36
-0.05
-0.06
Basic Weighted Avg Shares
- -
- -
2
2
2
2
1
1
2
30
44
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
6
4
1
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-127.48
-73.98
-258.17
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
-7
-3
-3
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-121.36
-84.69
-237.73
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
3
-2
-3
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
3
-2
-3
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
-58.15
-70.58
-87.9
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Sep'22
Dec'22
Mar'22
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
52
52
52
Market Capitalization
5
3
2

Working Capital

FRC

•

in mil. unless spec.
Sep'22
Dec'22
Mar'22
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
1
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
3
3
4
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
1

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
134.14%
-152.57%
Free Cash Flow
- -
1,083.09%
-70.92%
Net Income, GAAP
- -
976.07%
-52.92%
Sales/Revenue/Turnover
- -
- -
-32.54%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
1
1
- -
2
4
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-0.01
-0.04
- -
- -
-0.11
2022
-0.01
-0.01
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Corey Mangold
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
27762 Antonio Parkway Ladera Ranch CA United States of America 92694
IPO Date
Apr 10, 2019
Website
orchidessentials.com
Similar Companies
Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS)
Vivesto AB (OASM.ST)
Cronos Group Inc. (CRON)
Cosmo Pharmaceuticals N.V. (CMOPF)
Achyut Healthcare Limited (ACHYUT.BO)
Vibe Growth Corporation (VIBE.CN)
Business
Orchid Ventures, Inc. (ORVRF) engages in the design, development, manufacturing, branding, and distribution of cannabis vape products and related hardware in North America. The company offers cannabis vapor devices including kits, cartridges, 510-thread batteries, ultra-portable pod-based systems, and disposable vaporizers under the Orchid Essentials brand; it also provides proprietary PurGuard technology platforms, emissions-tested clean vaporizer hardware through its subsidiary PurTec Delivery Systems, LLC, and white-label co-branded product development services including oil sourcing, filling, compliance management, and distribution via the Orchid Platform. Products target the cannabis and CBD industries, serving licensed manufacturers, distributors, processors, retailers, and consumers through approximately 150 to 350 dispensaries primarily in California, Oregon, and Nevada. Founded as a California-based cannabis innovation company and headquartered in Ladera Ranch, California, Orchid Ventures licenses its brands and hardware globally while focusing on premium, user-optimized experiences. Recent developments include the 2022 launch of PurTec Delivery Systems as a dedicated hardware subsidiary to expand proprietary delivery systems beyond vaporizers; a sales and distribution agreement with Landrace, LLC to boost market penetration; termination and renewal of a licensing agreement for Orchid Essentials in Oregon; a new CFO appointment following Richard Brown's resignation; and a share consolidation with an over-subscribed private placement closing in 2021 alongside ongoing stock option grants and financial reporting showing diversification efforts amid revenue from non-vape cannabis and CBD segments.

Company News

APIChat

  • accesswire.com

    Orchid Ventures Announces Shareholder Update Conference Call

  • prnewswire.com

    Eybna Announces Q3 Partnerships with Legacy Brands, Fueling National Expansion

  • accesswire.com

    Orchid Ventures Announces Highest Month of Sales Closed in Nine Months

  • prnewswire.com

    Orchid Ventures Announces the PurGuard Vape Software Platform With Age Verification to Limit Vape Usage by Minors

  • accesswire.com

    Orchid Ventures Announces Its CEO to Speak at the Summer Emerge Conference

  • accesswire.com

    Orchid Ventures Consolidated its Shares and Closes Over-Subscribed Private Placement of Units

  • accesswire.com

    Orchid Ventures Amends the Terms of Warrants Issued in 2019

  • accesswire.com

    Orchid Ventures Announces Proposed Share Consolidation, Private Placement of Units and Shares for Debt Settlement

  • accesswire.com

    Orchid Ventures Reports Annual Financial Results for Fiscal Year 2020

  • accesswire.com

    Orchid Ventures Provides Financial Filings Update